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Background: Ventricular septal rupture (VSR) is an uncommon but well-recognized mechanical complication of
acute myocardial infarction (AMI). The outcome of VSR remains poor even in the era of reperfusion therapy. We
reviewed our experience with surgical repair of post-infarction VSR and analyzed outcomes in an attempt to identify
prognostic factors.
Methods: From October 1995 to December 2013, data from 47 consecutive patients (mean age, 68 ± 9.5 years) with
post-infarction VSR who underwent surgical repair at our institute were retrospectively reviewed. The preoperative
conditions, morbidity and surgical mortality were analyzed. Multivariate analysis was subsequently carried out by
constructing a logistic regression model in order to identify independent predictors of postoperative mortality. Long
term survival function were estimated using the Kaplan-Meier method and compared using the log-rank test.
Results: Percutaneous coronary intervention was performed in 17 (36.2%) patients, intra-aortic balloon pump (IABP)
was used in 34 (72.3%), and six (12.8%) were supported with extracorporeal membrane oxygenation (ECMO)
preoperatively. Forty-one (87.2%) patients received emergent surgical treatment. Concomitant coronary artery bypass
grafting was performed in 27 (57.4%) patients.
Operative mortality was 36.2% (17 of 47). The survival rate was 59.3% with concomitant CABG and 70% without
concomitant CABG (p = 14). Multivariate analysis revealed that the survivors had higher preoperative left ventricular
ejection fractions (LVEFs) compared with those who died (51 ± 13.7% vs. 36.6 ± 6.4% , respectively; p < 0.001) and
lower European system for cardiac operative risk evaluation II (EuroSCORE II) (22.9 ± 14.9 vs. 38.3 ± 13.9, respectively;
p < 0.001). The patients receiving total revascularization has long term survival benefit (p = 0.028).
Conclusions: Post-infarction VSR remains a serious and challenging complication of AMI in the modern surgical era.
The EuroSCORE II can be used for an approximate prediction of operative mortality. Preserved LVEF was associated
with better prognosis, while the need for postoperative RRT was associated with higher early and late mortality.
Besides, the strategy of total revascularization should be applied to ensure long-term survival benefit.
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Ventricular septal rupture (VSR) is a fatal complication
following acute myocardial infarction (AMI). The inci-
dence of VSR complicating AMI was 1-3% in the era
prior to widespread reperfusion therapy [1]. Since the
introduction of thrombolytic therapy, the incidence has
declined to approximately 0.3% [2]. After undergoing a
primary percutaneous coronary intervention (PCI), VSR
was reported to occur in 0.23-0.71% of patients [3-5].
Treatment of VSR after AMI is a surgical challenge
and the surgical mortality rate of post-infarction VSR
remains high. A reported mortality of 34%-54% has
remained relatively constant during the past two decades
[6-9]. We reviewed our experience of post-infarction
VSR and analyzed the surgical outcomes in an attempt
to identify risk factors associated with mortality.
Methods
This study was approved by the Institutional Review
Board of our institute (201405033RINA) and informed
consent was waived. During the period from 1995 to
2013, patients with a diagnosis of AMI complicated by
VSR were retrieved from the registration database of our
hospital using ICD-9 codes (ICD-9 code 429.71, I232).
The demographic data, clinical presentation, surgical
management, and outcomes were reviewed. Patients
who underwent concomitant coronary revascularization
procedures were also included.
Surgical technique
The operation was performed with standard cardiopul-
monary bypass (CPB). The VSR repair was performed
with the concept of “infarct exclusion” [10,11], as shown
in Figure 1.Figure 1 VSR repair is performed with the concept of “infarct
exclusion”. The LV incision is made parallel to the left anterior
descending artery, the patch is sutured on the healthy myocardium
using 3–0 pledgetted prolene interrupted suture, and the LV
ventriculotomy is closed, excluding the infarcted myocardium from
the high pressure of the LV cavity.The left ventricle was incised to expose the location of
the VSR, and margins of the infarcted muscle were iden-
tified. If it was difficult to expose the location of VSR,
such as posterior ventricular septal rupture, the longitu-
dinal right atriotomy was performed to expose the
location and margin. The patch (either xenograft or
prosthetic) was tailored in the shape of the left ventricu-
lar infarction and then sutured to a portion of the non-
infarcted interventricular septum with intermittent
pledgetted 3–0 polypropylene suture. After the VSR was
repaired, the LV was closed with 2–0 prolene with felt
strips for enforcement. According to our strategy, the
application of complete revascularization was not carried
out in all patients. If PCI was not performed before the
operation or culprit-only percutaneous coronary inter-
vention was performed, concomitant coronary artery
bypass grafting (CABG) to the stenotic vessels was
undertaken, if feasible.
Variables
The demographic characteristics, medical co-morbidities
(smoking history, hypertension, diabetes mellitus, previ-
ous cerebrovascular accident, and renal function), med-
ical acuity (prodromal angina, left ventricular ejection
fraction (LVEF), and Killip classification), the location of
infarction, site of septal rupture, and preoperative peak
cardiac enzymes were obtained by chart review. Pro-
dromal angina was defined as typical chest pain episodes
(either at rest or upon effort) persisting < 30 minutes
and occurring within 24 hours before the onset of the
AMI [12].
The use of early PCI (≤6 hours after AMI), intra-aortic
balloon pump (IABP), concomitant surgical procedures,
and calendar year of operation were also included as
variables for analysis.
The surgical condition was defined according to the
clinical status of the patient at the time of surgery [6].
Elective status was defined as routine admission for the
operation. Emergent status was defined as surgery for
those patients with hemodynamic instability, including
hypotension or tachyarrhythmia, even under use of ino-
tropic agents or placement of an intra-aortic balloon
pump.
The ratio of pulmonary to systemic blood flow was
calculated using the Swan-Ganz catheter data, i.e.,
Qp/Qs = SAoO2 – SRAO2/SPVO2 – SPAO2, where Ao =
aorta, RA = right atrial, PV = pulmonary vein, and PA =
pulmonary artery. SaO2 was substituted for SPVO2 if SaO2
was not available.
To determine if the European system for cardiac
operative risk evaluation (EuroSCORE) could predict op-
erative mortality in patients with myocardial infarction
complicating VSR, we calculated the EuroSCORE II for
each patient [13].
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The early outcome was operative mortality, defined as
death from any cause in-hospital or within 30 days
of the index operation [6]. Outcome data for opera-
tive mortality and subsequent survival were obtained
for all patients from hospital medical records until
March 2014.
The secondary outcome included length of ICU stay
and morbidities such as postoperative pneumonia, acute
kidney injury (AKI) after operation requiring renal re-
placement therapy (RRT), cerebrovascular accident,
re-exploration for bleeding, and residual VSR.
AKI was defined using the KDIGO (Kidney Disease/
Improving Global Outcomes) clinical practice guide-
line. Stage 1, according to this guideline was defined
as an increase in serum creatinine of ≥ 0.3 mg/dL
(≥26.5 μmol/L) within 48 hours or an increase in serum
creatinine of ≥ 1.5 times baseline (which was known or
presumed to have occurred within the prior seven days),
or urine output < 0.5 mL/kg/h for 6 hours [14]. Patients
that met the definition for AKI were staged according to
severity, including an increase in serum creatinine or
reduction in urine output, as shown in Table 1.
It remains unclear whether patients with AKI after
cardiac surgery would benefit from the early institution
of pharmacologic agents or the early initiation of RRT
[15]. In current practice, the decision to start RRT is
based on clinical features of volume overload and bio-
chemical features of solute imbalance (azotemia, hyper-
kalemia, or severe acidosis). Postoperative RRT was
required in approximately 1-8% of these patients afterTable 1 Staging of acute kidney injury based on KDIGO
Clinical Practice Guidelines for Acute Kidney Injury [14]
Stage Serum creatinine Urine output
1 1.5–1.9 times baseline <0.5 ml/kg/h for 6–12
hours
OR
≥0.3 mg/dl (≥26.5 mmol/l) increase
2 2.0–2.9 times baseline <0.5 ml/kg/h for ≥12 hours
3 3.0 times baseline <0.3 ml/kg/h for ≥24 hours
OR OR
Increase in serum creatinine to
≥4.0 mg/dl (≥353.6 mmol/l)
Anuria for ≥12 hours
OR
Initiation of renal replacement
therapy
OR,
In patients <18 years, decrease in
eGFR to <35 ml/min per 1.73m2
Adapted from [14]: Improving Global Outcomes (KDIGO) Acute Kidney Injury
Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Section
2: AKI definition. Table 2. Staging of AKI. Kidney International Supplements
2012;2:19. http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO%
20AKI%20Guideline.pdf.cardiac surgery and this treatment was associated with
increased mortality and hospitalization costs [16,17].
Late outcome
Follow-up data were obtained by consulting the hospital
medical records and by telephoning patients or their
families.
Statistical analysis
Summary statistics for outcomes and baseline patient char-
acteristics were expressed as percentages for categorical
variables and as mean ± standard deviation (SD) for con-
tinuous variables. The Chi-square test was used to com-
pare categorical variables, whereas the Student t-test was
used for continuous variables. Subsequently, multivariate
analysis was carried out by constructing a logistic regres-
sion model with the above-mentioned variables in order to
identify independent predictors of postoperative mortality.
Survival functions were estimated using the Kaplan-
Meier method and compared using the log-rank test.
We calculated the risk ratios at specific points, using the
estimated rates of survival for patients with/without
complete revascularization. A multivariate Cox propor-
tional hazard analysis was performed to identify the
independent factors affecting long-term survival. A two-




During the period from 1995 to 2013, there were 4761
patients diagnosed with AMI and admitted to our
hospital. Among them, 47 (0.98%) patients had AMI
complicated by VSR.
Clinical characteristics
The patients’ demographic characteristics are presented
in Table 2. The average age at operation was 68.9 ± 9.5
years and men accounted for 59.6% of the patients. Most
of the patients (85.1%) had one or more comorbidities of
which hypertension was the most common (61.7%),
followed by diabetes mellitus (44.7%).
The time between diagnosis of AMI and VSR repair
was 5.3 ± 10.4 days (Figure 2). Emergency surgery was
performed in 41(87.2%) patients. Before operation, 34
patients (72.3%) were supported by IABP and the major-
ity of patients at the time of diagnosis of AMI were
Killip class III (n = 15, 31.9%) or class IV (n = 19, 40.4%).
Anterior myocardial infarction (n = 42, 89.4%) was the
most common location of myocardial infarction. The
apical VSR (n = 36, 76.6%) was the most common
VSR location, while there were 11 patients with the
posterior VSR. The average LVEF before operation was
45.8 ± 13.5% (Table 2).
Table 2 Characteristics of the 47 patients with ventricular
septal rupture after acute myocardial infarction
Profile Mean ± SD or
No.(%)
Demographics
Age, years 68.9 ± 9.5
Male sex 28(59.6%)































CK 1392.1 ± 1208.3
CK-MB 115.9 ± 127.0









Table 2 Characteristics of the 47 patients with ventricular
septal rupture after acute myocardial infarction
(Continued)
OP characteristics
Repair from MI, days 6.3 ± 10.4
Emergency surgery 41(87.2%)
Concomitant CABG 27(57.4%)
CPB time 193.9 ± 50.4
AXC time 113 ± 46.9
Abbreviations: IABP intra-aortic balloon pump; ECMO extracorporeal membrane
oxygenation; V-D vessel disease; CK creatinine kinase; CK-MB creatinine kinase
MB fraction; EuroSCORE II European system for cardiac operative risk evaluation
II; Qp/Qs ratio of pulmonary to systemic blood flow; PCI percutaneous coronary
intervention; MI myocardial infarction; CABG coronary artery bypass grafting;
CPB cardiopulmonary bypass; AXC aortic cross-clamp.
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formed in 18 patients. Among them, 17 patients received
PCI and 12 received thrombolysis.
During the operation, all had VSR repaired with
patches and pledgetted-prolene suture; no closure de-
vices were used. Concomitant CABG was performed in
27 patients (57.4%). The duration of CPB was 194 ± 50
minutes and aortic clamp-time was 113 ± 47 minutes, as
shown in Table 2.
Early outcomes
The operative mortality was 36.2% (n = 17) and the me-
dian ICU stay of the survivors was 15 days.
Postoperative morbidity was common, including cere-
bral vascular accident in five (10.6%) patients, AKI re-
quiring RRT in 21 (48.8%), pneumonia in 20 (42.6%),
and heart block in seven (14.9%). Eleven (23.4%) patients
required re-exploration for mediastinal bleeding. Re-
sidual ventricular septal defect was noted in 16 patients
(34%), including eight who were diagnosed during ICU
admission (Table 3).
From Table 4, age, gender, preoperative co-morbidity,
Killip class, number of diseased coronary arteries, loca-
tion of VSR, Qp/Qs, peak cardiac enzymes, and revascu-
larization before operation were not significantly
different between survivors and non-survivors. The op-
erative mortality rate did not vary by the interval be-
tween diagnosis of AMI and repair (p = 0.19). There was
no significant difference in the duration of aortic cross-
clamping between survivors and non-survivors (109 ± 44
minutes vs. 123 ± 55 minutes, respectively, p = 0.424). In
addition, the use of prior coronary reperfusion therapy
and concomitant CABG were not significantly different
between survivors and non-survivors (76.7% vs. 74.5%,
respectively; p = 0.646).
The survivors had a higher LVEF than the non-
survivors (51 ± 13.7% vs. 36.6 ± 6.4%, p = 0.001). The pa-





















Time from on set of AMI till VSR operation
Figure 2 Based on the time between diagnosis of myocardial infarction and surgery, most surgeries are performed as urgent or emergent
operations after diagnosis is confirmed.
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repair (n = 6) (41.5% vs. 0%, respectively; p = 0.048).
The EuroSCORE II was significantly higher in the
non-survivors than the survivors (38.3 ± 13.9 vs. 22.9 ±
14.9, respectively, p =0.001). A higher EuroSCORE II
predicted a higher possibility of operative mortality. In
this study population, EuroSCORE II had excellent dis-
criminatory power for operative mortality, with an area
under the curve (AUC) of 0.781(Figure 3).
Postoperative morbidity was common in both survivors
and non-survivors, while the non-survivors required more
frequent postoperative dialysis (86.7% vs. 28.6%, respect-
ively; p = 0.001; Table 4). The operative mortality over the
most recent 8 years (2006–2013) was 16.67% (3/18), much
lower than previous 11 years(1995–2005) operative mor-
tality [48.28% (14/29); p = 0.028].
Significant predictors of operative mortality based
on univariate analysis included LVEF, EuroSCORE II,Table 3 Post-operative outcome of the 40 patients with
ventricular septal rupture
Postoperative outcomes Mean ± SD or No.(%)
Length of hospitalization, days 44.9 ± 36.0
ICU stay of survivors, days 24.9 ± 27.3
Cerebrovascular accident 5(10.6%)
Renal replacement therapy 21(48.8%)
Pneumonia 20(42.6%)
Heart block 7(14.9%)
Reexploration for bleeding 11(23.4%)
Residual VSD 16(34%)
Abbreviations: ICU intensive care unit; VSD ventricular septal defect;
SD standard deviation.emergent surgical status, two consecutive period cohort
effect, and postoperative RRT. Logistic regression for
multivariate analysis showed that the LVEF and postop-
erative RRT were independent risk factors for operative
mortality, as shown in Table 4.
Late outcome
Follow-up was complete in 93.3% of patients with two
patients lost to follow-up. The overall average follow-up
period was 99.1 months (range, 72.8-125.3) for the 28
patient survivors. Figure 4 shows the Kaplan-Meier esti-
mate of overall survival, including operative deaths.
Overall survival at 6 years was 41.1 ± 2.2%.
Based on multivariate Cox regression analysis, the fac-
tor that had a significant positive impact on late survival
was total revascularization of stenotic coronary arteries.
Figure 4 demonstrates an increasing survival benefit for
the patients receiving total revascularization (p = 0.028).
Discussion
This study examined outcomes in 47 patients with VSR
following AMI who underwent surgical repair over a 19
year period at our institution. The observed incidence of
VSR complicating AMI was 0.98%, which was lower than
the incidence quoted from pre-thrombolytic era studies,
but slightly higher than the incidence (0.2 ~ 0.4%) reported
in the Global Utilization of Streptokinase and t-PA for
Occluded Coronary Arteries (GUSTO-I) trial of more than
41,000 patients treated for myocardial infarction in the
thrombolytic era [2]. However, since our study was per-
formed at a tertiary medical center, our patients may have
had a higher disease severity. In addition, some patients
were referred after diagnosis of VSR, which could have in-
creased our observed incidence.
Table 4 Comparison of clinical characteristics between Survivors and Nonsurvivors
Variable Survivors (N = 30) Nonsurvivors (N = 17) p value Multi-varible p
Demographics
Age, years 68.0 ± 7.9 70.5 ± 11.9 0.402
Male sex 18(60%) 10(58.8%) 0.937
Body weight 62 ± 10.4 63.4 ± 10.0 0.661
Comorbidities
Hypertension 21(70%) 8(47.1%) 0.120
Diabetes mellitus 15(50%) 6(35.3%) 0.330
Smoking 7(23.3%) 7(41.2%) 0.199
Dialysis 2(6.7%) 2(11.8%) 0.547
Estimated Creatinine Clearance Rate 45.9 ± 18.2 41.3 ± 24.6 0.467
History of Cerebrovascular accident 4(13.3%) 3(17.6%) 0.690
Acuity
Pre-operative mechical support
IABP 20(66.7%) 14(82.4) 0.248
ECMO 4(13.3%) 2(11.8%) 0.877
Prodromal Angina 21(70%) 8(47.1%) 0.120
Killip class
I 4(13.3%) 2(11.8%) 0.877
II 5(16.7%) 2(11.8%) 0.650
III 9(30%) 6(35.3%) 0.708
IV 12(40%) 7(41.2%) 0.937
Coronary artery disease
1-V-D 12(40%) 4(23.5%) 0.252
2-V-D 4(13.3%) 6(35.3%) 0.077
3-V-D 14(46.7%) 7(41.2%) 0.716
LV Ejection fraction 51 ± 13.7 36.6 ± 6.4 0.001 0.00.3
Cardiac emzyme
CK 1436.4 ± 1287.2 1324.3 ± 1116.5 0.784
CK-MB 129.3 ± 142.6 95.2 ± 99.5 0.425
EuroSCORE II 22.9 ± 14.9 38.3 ± 13.9 0.001 0.183
Revascularization
PCI 11(36.7%) 6(35.3%) 0.925
Thrombolysis 7(23.3%) 5(29.4%) 0.646
AMI/VSD characteristics
Anterior MI 27(90%) 15(88.2%) 0.850
Apical rupture 24(80%) 12(70.6%) 0.464
Ventricular Aneurysm 15(50%) 5(29.4%) 0.17
Qp/Qs 2.8 ± 1.6 3.2 ± 1.68 0.538
Operative characteristics
Repair from MI, days 7.8 ± 12.5 3.7 ± 3.7 0.190
Emergency surgery 24(80%) 17(100%) 0.048 0.093
Concomitant CABG 16(53.3%) 11(64.7%) 0.449
CPB time 189.1 ± 44.2 205.7 ± 64.2 0.364
AXC time 109.1 ± 44.0 122.7 ± 54.6 0.424
Cohort effect (2007-2013) 15(50%) 3(17.6%) 0.028 0.649
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Table 4 Comparison of clinical characteristics between Survivors and Nonsurvivors (Continued)
Post-opearative outcome
Cerebrovascular accident 2(6.7%) 3(17.6%) 0.241
Renal replacement therapy 8(28.6%) 13(86.7%) 0.001 0.001
Pneumonia 11(36.7%) 9(52.9%) 0.278
Heart block 5(16.7%) 2(11.8%) 0.650
Reexploration for bleeding 4(13.3%) 7(41.2%) 0.030 0.322
Residual VSD 9(30%) 7(41.2%) 0.437
Abbreviations: IABP intra-aortic balloon pump; ECMO extracorporeal membrane oxygenation; V-D vessel disease; CK creatinine kinase; CK-MB creatinine kinase
MB fraction; EuroSCORE II European system for cardiac operative risk evaluation II; Qp/Qs ratio of pulmonary to systemic blood flow; PCI percutaneous
coronary intervention; MI myocardial infarction; CABG coronary artery bypass grafting; CPB cardiopulmonary bypass; AXC aortic cross-clamp; VSD ventricular
septal defect.
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consistent with the 34-54% operative mortality rate
seen in previous studies [6-9]. In addition, we found
that the operative mortality of VSR complicating
AMI was much lower during the previous 8 years
(2006–2013) (3/18, 16.67%) compared with the previ-
ous 11 years (1995–2005) 14/29, 48.28%, respectively;
p = 0.028). In the study by Figueras et al., in-hospital
deaths for patients with AMI and cardiac rupture
declined over time and most were due to cardiac
causes [5].Figure 3 The receiver operating characteristic (ROC) curve shows the relat
analysis, EuroSCORE II has excellent discriminatory power for operative morFor our whole cohort, the predicted mortality rate by the
EuroSCORE II was 28.5 ± 16.2%. We observed a higher
mortality than predicted by the EuroSCORE II. The non-
survivors had a higher EuroSCORE II than the survivors
(38.4 ± 13.9% vs. 22.9 ± 14.9, respectively; p = 0.001).
The EuroSCORE II scoring system is commonly ap-
plied in cardiac surgery, including CABG and valvular
surgery. EuroSCORE II reflects better current surgical
performance and offers a new quality standard to evalu-
ate clinic outcomes [13,18]. The discriminatory ability of
the EuroSCORE II for operative mortality by area underionship between EuroSCORE II and operative mortality. By ROC curve
tality, with an area under the curve (AUC) of 0.781.
Figure 4 Kaplan-Meier survival curve. Log-rank p = 0.028.
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EuroSCORE II’s predicted operative mortality was over-
estimated in previous studies [19,20], the EuroSCORE II
did not overestimate mortality in this study and can
reflect the mortality risk in a small group of patients.
In a previous study [21], higher postoperative mortal-
ity, longer intensive care unit stays, and longer hospital
stays were observed in patients who underwent CABG
with lower LVEF. Similar to the findings of Philip et al.
[22], our data showed that preserved LVEF had a posi-
tive impact on early survival. In post-infarct VSR, car-
diogenic shock is due, in part, to a decreased myocardial
contractility in the infarcted area, and is also secondary
to the presence of a left-to-right shunt. Thus, the low
LVEF might imply less myocardial reserve after VSR re-
pair and, thus, may have contributed towards a higher
mortality rate.
The patents in our cohort who underwent a lower-risk
elective procedure at a later time achieved better sur-
vival although the difference was not significant upon
multivariate analysis. Medical therapy or mechanical
support (such as IABP) can stabilize the hemodynamic
status of patients and with careful monitoring allow
elective surgery at a later time. A longer interval before
surgery has been associated with improved survival
[1,23,24]. Delayed elective repair allows for myocardial
scar tissue formation which may facilitate the technicalaspects of VSR repair. Despite this, a longer interval be-
tween diagnosis of AMI and repair did not significantly
improve survival.
We also observed that postoperative AKI requiring
dialysis was independently associated with mortality and
these same findings have been previously reported [22].
Renal dysfunction in the surgical patient is usually multi-
factorial. The most common cause is ATN as a result of
hypoxic damage to nephrons in the medullary region of
the kidney secondary to hypotension, hypovolemia, and
dehydration. Patients with post-infarction VSR experi-
enced cardiogenic shock, CPB, and/or circulatory arrest.
Postoperative AKI is a serious condition that carries a
considerable mortality. The incidence of acute renal fail-
ure after CABG requiring dialysis is less than 2%, but in
such cases, the mortality varies between 23 and 88%
[25-27]. Therefore, prevention of organ injury (including
prevention of shock and preservation of organ perfusion)
is important in improving survival.
Lundblad et al. [28] found that concomitant CABG
during VSR repair reduces both early and late mortality
when compared with patients with unbypassed coronary
artery disease. In a review of recent literature, Perotta
et al. [29] also reported an improvement in mortality
rates in those patients who had undergone CABG. These
results were applied to patients with multi-vessel disease
where complete myocardial revascularization was achieved
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farcted areas. Our study found that concomitant CABG
did not confer a protective effect in early mortality, but a
pronounced survival benefit was provided by the total
revascularization during long-term follow-up.
Limitations
Our study had several limitations. Due to its retrospect-
ive design, we were unable to certify that all potential
confounding factors had been record. Due to the rela-
tively rare occurrence of post-infarction VSR, the small
sample size underpowered the statistical analysis and
could have limited the number of statistically significant
variables. During the study period, the revascularization
by PCI and surgical techniques may have improved as
our experience accumulated. Our single center experi-
ence may not be applicable to other institutes.
Conclusions
Post-infarction VSR carries significant mortality (36.2%)
despite aggressive surgical management. The surgical
results have shown improvement in recent years (2006–
2013). The EuroSCORE II can be used to make an
approximate prediction of operative mortality. Preserved
LVEF had a beneficial effect on early prognosis, while
the need for postoperative RRT was associated with
higher early and late mortality. The strategy of total re-
vascularization should be applied to ensure long-term
survival benefit.
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